The US Patent and Trademark Office (USPTO) has issued new patent covering OXiGENE benzosuberene-based compounds and methods of using them in tubulin polymerization inhibition. The patent protects benzosuberene-based compounds including ...
Tags: Health, OXiGENE, Oxigene Benzosuberene-Based Compounds
Clinical-stage biopharmaceutical company OXiGENE's acute myelogenous leukemia (AML) drug candidate, OXi4503, has received FDA orphan drug status. The second-generation anticancer agent with a dual-mechanism vascular disrupting feature ...